Plunkett Research Online: Aytu BioScience

AYTU BIOSCIENCE (AYTU:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Aytu BioScience Inc is a specialty pharmaceutical company commercializing novel products addressing patient needs. The company markets a portfolio of prescription products addressing large therapeutic markets. The primary care portfolio includes Natesto, the only FDA-approved nasal formulation of te.....



Aytu BioScience
Ticker: AYTU
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 720 437-6580
Fax:
Address: 373 Inverness Parkway
Suite 206
Englewood, CO 80112 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Specialty Schools and Instruction
ContactsDescription

Joshua DisbrowCEO/Chairman of the Board/Director
David GreenCFO/Chief Accounting Officer/Secretary/Treasurer
See More
Aytu BioScience Inc is a specialty pharmaceutical company commercializing novel products addressing patient needs. The company markets a portfolio of prescription products addressing large therapeutic markets. The primary care portfolio includes Natesto, the only FDA-approved nasal formulation of te.....See More See More

Auditor: Plante & Moran, PLLC
Legal Advisor: Davidson & Shear
$USD, In whole numbers,
except marked * or %
201920182017201620152014
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: